Synthesis of a Library of Indolizines Using Poly(ethylene glycol) as Soluble Support

Abstract

A library of indolizines has been synthesized using poly(ethylene glycol) (PEG) as soluble polymer support. The PEG-supported pyridinium ylide reacted with alkenes or alkynes to give PEG-bound indolizines. Cleavage from the soluble polymer support was induced by KCN/MeOH to afford the indolizines. This synthetic method is simple, the reaction conditions are mild and the yields are high to excellent.

poly (ethylene glycol) - cycloaddition - pyridinium salt - indolizine - polymer-support

References

<A NAME="RU05104ST-1">1</A> Sonnenschein H. Kosslick H. Tittelbach F. Synthesis  1998,  1596 

<A NAME="RU05104ST-2">2</A> Kreher T. Sonnenschein H. Costisella B. Schneider M. J. Chem. Soc., Perkin Trans. 1  1997,  3451 

<A NAME="RU05104ST-3">3</A> Blake AJ. Dick JW. Leaver D. Strachan P. J. Chem. Soc., Perkin Trans. 1  1991,  2991 

<A NAME="RU05104ST-4">4</A> Poissonnet G. Theret-Bettiol M.-H. Dodd RH. J. Org. Chem.  1996,  61:  2273 

<A NAME="RU05104ST-5">5</A> Harrell WB. Doerge RF. J. Pharm. Sci.  1967,  56:  225 

<A NAME="RU05104ST-6">6</A> Wheeler JW. inventors; Eur. Pat. Appl. EP  161789.  ; Chem. Abstr. 1985, 104, 170108

<A NAME="RU05104ST-7">7</A> Weidner CH. Wadsworth DH. Bonder SL. Beltman DJ. J. Org. Chem.  1989,  54:  3660 

<A NAME="RU05104ST-8A">8a</A> Gubin J. Lucchetti J. Nisato D. Rosseels G. Clinet M. Polster P. J. Med. Chem.  1992,  35:  981 

<A NAME="RU05104ST-8B">8b</A> Nugent RA. Murphy M. J. Org. Chem.  1987,  52:  2206 

<A NAME="RU05104ST-9">9</A> Chai W. Kwok A. Wong V. Carruthers NI. Wu J. Synlett  2003,  2086 

<A NAME="RU05104ST-10A">10a</A> Katritzky AR. Qiu G. Yang B. He HY. J. Org. Chem.  1999,  64:  7618 

<A NAME="RU05104ST-10B">10b</A> Zhang XC. Huang WY. J. Fluorine Chem.  1998,  92:  13 

<A NAME="RU05104ST-10C">10c</A> Zhu SZ. Qin C. Wang Y. Chu Q. J. Fluorine Chem.  1999,  99:  183 

<A NAME="RU05104ST-10D">10d</A> Zhang X. Cao W. Wei X. Hu H. Synth. Commun.  1997,  27:  1395 

<A NAME="RU05104ST-10E">10e</A> Wang B. Zhang X. Li J. Hu Y. Hu H. J. Chem. Soc., Perkin Trans. 1  1999,  1571 

<A NAME="RU05104ST-10F">10f</A> Druta II. Andrei MA. Aburel PS. Tetrahedron  1998,  54:  2107 

<A NAME="RU05104ST-10G">10g</A> Druta II. Dinica RM. Bacu E. Humelnicu I. Tetrahedron  1998,  54:  10811 

<A NAME="RU05104ST-11">11</A> Zhou J. Hu Y. Hu H. Synthesis  1999,  166 

<A NAME="RU05104ST-12A">12a</A> Basavaiah D. Rao AJ. Chem. Commun.  2003,  604 

<A NAME="RU05104ST-12B">12b</A> Chai W. Breitenbucher JG. Kwok A. Li X. Wong V. Carruthers NI. Lovenberg TW. Mazur C. Wilson SJ. Axe FU. Jones TK. Bioorg. Med. Chem. Lett.  2003,  13:  1767 

<A NAME="RU05104ST-13A">13a</A> Matsumato K. Hayashi N. Ikemi Y. Toda M. Uchida T. Aoyama K. Miyakoshi Y. J. Heterocycl. Chem.  2001,  38:  371 

<A NAME="RU05104ST-13B">13b</A> Peng W. Zhu S. J. Chem. Soc., Perkin Trans. 1  2001,  3204 

<A NAME="RU05104ST-13C">13c</A> Boultadakis E. Chung B. Elsegood MRJ. Weaver GW. Synlett  2002,  1547 

<A NAME="RU05104ST-13D">13d</A> Shen Y. Zhang Y. Jiang G. Synthesis  2002,  714 

<A NAME="RU05104ST-13E">13e</A> Chen WK. Qing Y. Synthesis  2003,  35 

<A NAME="RU05104ST-14">14</A> Bora U. Saikia A. Boruah RC. Org. Lett.  2003,  5:  435 

<A NAME="RU05104ST-15">15</A> Goff DA. Tetrahedron Lett.  1999,  40:  8741 

<A NAME="RU05104ST-16A">16a</A> Chen Z. Yang G. Zhang Z. Wang D. Synthesis  2001,  1483 

<A NAME="RU05104ST-16B">16b</A> Yang G. Chen Z. Zhang Z. Qiu X. Synth. Commun.  2002,  32:  3637 

<A NAME="RU05104ST-16C">16c</A> Chen Z. Yang G. Zhang Z. Synth. Commun.  2003,  33:  729 

<A NAME="RU05104ST-16D">16d</A> Yang G. Chen Z. Zhang G. Chin. J. Chem.  2002,  20:  178 

<A NAME="RU05104ST-16E">16e</A> Hu C. Chen Z. Yang G. Chin. J. Chem.  2003,  10:  1494 

<A NAME="RU05104ST-17">17</A>

Preparation of PEG-Supported Pyridinium Salt 2 To a solution of PEG₃₄₀₀ (8 g, 4.71 mmol OH) and DIPEA (1.6 mL, 9.42 mmol) in dry CH₂Cl₂ (50 mL) was added dropwise a solution of bromoacetyl bromide (0.8 mL, 9.42 mmol) in dry CH₂Cl₂ (2 mL) at 0 °C and stirred at r.t. overnight. The mixture was washed with H₂O to remove NH₄Br, dried over MgSO₄ and concentrated. After precipitation with cold Et₂O, washing with cold Et₂O and drying under vacuum, a white solid 1 was obtained. Into a solution of 1 in dry CH₂Cl₂ (20 mL) was added pyridine (1.52 mL, 9.42 mmol) and stirred at r.t. for 18 h. After precipitation from cold Et₂O, the suspension was filtered and washed with cold Et₂O to give solid 2 (8.8 g, 98%). TLC (EtOAc-petroleum ether, 1:4) showed that the solid was free from any low molecular reactants and by-products.
IR (KBr): 2883, 1750, 1114 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.42 (d, 2 H, J = 6.6 Hz, α-pyridine), 8.68 (t, 1 H, J = 8.7 Hz, γ-pyridine), 8.19 (t, 2 H, J = 7.2 Hz, β-pyridine), 6.16 (s, 2 H, -CH₂COO-), 3.77-3.52 [m, 4n H, -O(CH₂CH₂O)_n-].

<A NAME="RU05104ST-18">18</A>

Typical Procedure for Preparation of Indolizines 5 A solution of 2 (2 g, 0.53 mmol), 3 (2.12 mmoL), TPCD (0.65 g, 1.06 mmoL) and DIPEA (0.18 mL, 1.06 mmol) in DMF (30 mL) was stirred at 80-90 °C for 3-4 h. After the solvent was evaporated under vacuum, the residue was added CH₂Cl₂ (50 mL) and filtered. The filtrate was washed with H₂O to remove NH₄Br, dried over MgSO₄, filtered, concentrated and precipitated with cold Et₂O to give 4. Product 4 was treated with a 1% solution of KCN in MeOH (30 mL) and stirred at r.t. overnight, evaporated MeOH and precipitated with cold Et₂O to give the crude products, which were purified by column chromatography on silica gel (EtOAc-petroleum ether, 1:4) to afford the pure 5.
5a: IR (KBr): 1678, 1635 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.65 (d, 1 H, J = 7.2 Hz, C-5), 8.08 (d, 1 H, J = 9.0 Hz, C-8), 7.46-7.03 (m, 12 H, C-6, C-7, Ph), 3.62 (s, 3 H,
-COOMe). Anal. Calcd for C₂₃H₁₇NO₃: C, 77.73; H, 4.82; N, 3.94. Found: C, 77.68; H, 4.80; N, 3.97.
5b: IR (KBr): 1684, 1633 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.64 (d, 1 H, J = 6.6 Hz, C-5), 8.04 (d, 1 H, J = 9.0 Hz, C-8), 7.47-6.88 (m, 11 H, C-6, C-7, Ph), 3.66 (s, 3 H, -COOMe), 2.22 (s, 3 H, Me). Anal. Calcd for C₂₄H₁₉NO₃: C, 78.03; H, 5.18; N, 3.79. Found: C, 78.00; H, 5.14; N, 3.82.
5c: IR (KBr): 1686, 1627 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.64 (d, 1 H, J = 4.2 Hz, C-5), 8.08 (d, 1 H, J = 7.8 Hz, C-8), 7.46-6.61 (m, 11 H, C-6, C-7, Ph), 3.71 (s, 3 H,
-COOMe), 3.67 (s, 3 H, -OMe). Anal. Calcd for C₂₄H₁₉NO₄: C, 74.79; H, 4.97; N, 3.63. Found: C, 74.81; H, 4.94; N, 3.67.
5d: IR (KBr): 1687, 1634 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.67 (d, 1 H, J = 6.6 Hz, C-5), 8.11 (d, 1 H, J = 9.0 Hz, C-8), 7.47-6.79 (m, 11 H, C-6, C-7, Ph), 3.67 (s, 3 H, -COOMe). Anal. Calcd for C₂₃H₁₆NFO₃: C, 73.99; H, 4.32; N, 3.75. Found: C, 73.96; H, 4.38; N, 3.79.
5e: IR (KBr): 1681, 1627 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.65 (d, 1 H, J = 7.2 Hz, C-5), 8.05 (d, 1 H, J = 9.0 Hz, C-8), 7.45-7.03 (m, 11 H, C-6, C-7, Ph), 3.65 (s, 3 H,
-COOMe). Anal. Calcd for C₂₃H₁₆NClO₃: C, 70.86; H, 4.14; N, 3.59. Found: C, 70.90; H, 4.14; N, 3.62.
5f: IR (KBr): 1686, 1634 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.65 (d, 1 H, J = 7.2 Hz, C-5), 8.05 (d, 1 H, J = 9.0 Hz, C-8), 7.45-7.03 (m, 11 H, C-6, C-7, Ph), 3.65 (s, 3 H,
-COOMe). Anal. Calcd for C₂₃H₁₆NBrO₃: C, 63.61; H, 3.71; N, 3.23. Found: C, 63.57; H, 3.74; N, 3,24.
5g: IR (KBr): 1686, 1629, 1531 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.66 (d, 1 H, J = 7.8 Hz, C-5), 8.00 (d, 1 H, J = 9.6 Hz, C-8), 7.47-7.09 (m, 11 H, C-6, C-7, Ph), 3.63 (s, 3 H, -COOMe). Anal. Calcd for C₂₃H₁₆N₂O₅: C, 69.00; H, 4.03; N, 7.00. Found: C, 68.71; H, 4.00; N, 6.75.
5h: IR (KBr): 1686, 1625, 1533 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.67 (d, 1 H, J = 6.6 Hz, C-5), 8.06 (d, 1 H, J = 7.2 Hz, C-8), 7.44-7.13 (m, 11 H, C-6, C-7, Ph), 3.63 (s, 3 H, -COOMe). Anal. Calcd for C₂₃H₁₆N₂O₅: C, 69.00; H, 4.03; N, 7.00. Found: C, 68.66; H, 4.05; N, 6.73.
5i: IR (KBr): 1682, 1628,1535 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.66 (d, 1 H, J = 7.2 Hz, C-5), 8.04 (d, 1 H, J = 8.4 Hz, C-8), 7.47-7.08 (m, 11 H, C-6, C-7, Ph), 3.63 (s, 3 H, -COOMe). Anal. Calcd for C₂₃H₁₆N₂O₅: C, 69.00; H, 4.03; N, 7.00. Found: C, 68.64; H, 4.02; N, 6.71.
5j: IR (KBr): 2226, 1682, 1628 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.66 (d, 1 H, J = 6.6 Hz, C-5), 8.03 (d, 1 H, J = 9.0 Hz, C-8), 7.45-7.09 (m, 11 H, C-6, C-7, Ph), 3.63 (s, 3 H, -COOMe). Anal. Calcd for C₂₄H₁₆N₂O₃: C, 75.78; H, 4.24; N, 7.36. Found: C, 75.74; H, 4.22; N, 7.38.
5k: IR (KBr): 1687, 1634 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.61 (d, 1 H, J = 6.0 Hz, C-5), 8.15 (d, 1 H, J = 8.4 Hz, C-8), 7.56-6.13 (m, 10 H, C-6, C-7, Ph, -furan), 3.82 (s, 3 H, -COOMe). Anal. Calcd for C₂₁H₁₅NO₄: C, 73.04; H, 4.38; N, 4.06. Found: C, 73.06; H, 4.34; N, 4.09.
5l: IR (KBr): 1688, 1647 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.59 (d, 1 H, J = 7.2 Hz, C-5), 8.65 (d, 1 H, J = 9.0 Hz, C-8), 7.62-6.49 (m, 5 H, C-6, C-7, -furan), 3.74 (s, 3 H,
-COOMe), 2.02 (s, 3 H, -Me). Anal. Calcd for C₁₆H₁₃NO₄: C, 67.84; H, 4.63; N, 4.94. Found: C, 67.88; H, 4.60; N, 4.87.
5m: IR (KBr): 1676, 1637 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.60 (d, 1 H, J = 6.6 Hz, C-5), 8.66 (d, 1 H, J = 9.0 Hz, C-8), 7.76-7.03 (m, 7 H, C-6, C-7, Ph, -furan), 3.52 (s, 3 H, -COOMe), 1.82 (s, 3 H, -Me). Anal. Calcd for C₁₈H₁₅NO₃: C, 73.71; H, 5.15; N, 4.78. Found: C, 73.76; H, 5.11; N, 4.82.
5n and 8b: IR (KBr): 1702, 1637 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.56 (d, 1 H, J = 7.2 Hz, C-5), 8.37 (d, 1 H, J = 7.8 Hz, C-8), 8.02 (s, 1 H, C-2), 7.36 (t, 1 H, J = 7.8 Hz, C-7), 7.03 (t, 1 H, J = 6.6 Hz, C-6), 3.95 (s, 3 H, -COOMe), 3.94 (s, 3 H, -COOMe). Anal. Calcd for C₁₂H₁₁NO₄: C, 61.80; H, 4.75; N, 6.01. Found: C, 61.77; H, 4.71; N, 6.00.

<A NAME="RU05104ST-19">19</A>

Typical Procedure for Preparation of Indolizines 8 A solution of 2 (2 g, 0.53 mmol), 6 (2.12 mmoL) and DIPEA (0.18 mL, 1.06 mmol) in toluene was stirred at 90 °C for 2 h. After solvent was removed, the residue was dissolved in CH₂Cl₂ (50 mL) washed, dried, filtered, concentrated, precipitated and cleaved by using the procedure described above for 5. The crude product was purified by column chromatography on silica gel (EtOAc-petroleum ether, 1:2) to afford pure 8.
8a: IR (KBr): 1736, 1715, 1697 cm^-1. ¹H NMR (600 MHz, CDCl₃): δ = 9.53 (d, 1 H, J = 6.6 Hz, C-5), 8.35 (d, 1 H, J = 9.0 Hz, C-8), 7.40 (t, 1 H, J = 7.8 Hz, C-7), 7.07 (t, 1 H, J = 7.2 Hz, C-6), 4.03 (s, 3 H, -COOMe), 3.92 (s, 3 H,
-COOMe), 3.92 (s, 3 H, -COOMe). Anal. Calcd for C₁₄H₁₃NO₆: C, 57.73; H, 4.50; N, 4.81. Found: C, 57.77; H, 4.51; N, 4.85.